The global orthopedic medical device firm, Zimmer Biomet Holdings, Inc., has announced it will disclose its financial results for the second quarter of 2026 before the U.S. stock market opens on Wednesday, July 29, 2026.

An investor conference call and webcast to discuss the results and provide a business update will follow at 8:00 a.m. Eastern Time on the same day.

This medical technology company, with a history of nearly a century, focuses on the design, development, and sale of orthopedic implants and related surgical products.

Its business spans multiple areas including knee and hip joints, sports medicine, as well as extremities and trauma.

According to the company's latest financial figures, revenue for the first quarter of 2026 reached $2.087 billion, marking a 9.3% increase year-over-year, while net profit attributable to shareholders reached $238 million, a significant 30.8% rise compared to the same period last year.

Geographically, the Americas market contributed approximately 63% of the revenue, Europe, the Middle East, and Africa accounted for about 23%, and the Asia-Pacific region represented around 13%.

The market will be closely watching the company's progress in areas such as digital surgery, robotic-assisted technology, and AI-driven solutions, which are seen as key drivers for its future growth.

Additionally, investors are expected to focus on the potential impacts of the current global macroeconomic environment and changes in healthcare industry policies on the company's performance.

The conference call will be hosted by the company's management team.

Investors can listen to the live webcast via the investor relations section of the company's official website, where a replay will also be made available following the conclusion of the call.